A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
-
Published:2022-02
Issue:1
Volume:20
Page:1-10
-
ISSN:1558-7673
-
Container-title:Clinical Genitourinary Cancer
-
language:en
-
Short-container-title:Clinical Genitourinary Cancer
Author:
Costello Brian A.ORCID,
Bhavsar Nrupen A.,
Zakharia Yousef,
Pal Sumanta K.,
Vaishampayan UlkaORCID,
Jim HeatherORCID,
Fishman Mayer N.,
Molina Ana M.,
Kyriakopoulos Christos E.,
Tsao Che-Kai,
Appleman Leonard J.,
Gartrell Benjamin A.,
Hussain Arif,
Stadler Walter M.ORCID,
Agarwal Neeraj,
Pachynski Russell K.,
Hutson Thomas E.,
Hammers Hans J.,
Ryan Christopher W.,
Mardekian JackORCID,
Borham Azah,
George Daniel J.,
Harrison Michael R.
Funder
Genentech
Exelixis
Genzyme
Bayer Fund
Merck
Novartis
Bayer
Pfizer Inc Boulder
Pfizer
AstraZeneca
Bristol-Myers Squibb
Sanofi
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献